Merck KGaA (XTER:MRK)
€ 141.85 0.25 (0.18%) Market Cap: 61.67 Bil Enterprise Value: 69.21 Bil PE Ratio: 23.06 PB Ratio: 2.19 GF Score: 85/100

Merck KGaA at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 12:30PM GMT
Release Date Price: €144.9 (+1.51%)
Richard Vosser
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, good afternoon, and welcome to the 39th JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. And it gives me great pleasure to introduce Stefan Oschmann, CEO of Merck KGaA from Germany in -- Darmstadt in Germany for this first presentation at the conference.

Before I hand over to Stefan, I will remind you that if you would like to ask a question during the Q&A portion of this session, then you can use the Q&A function at any time associated on the conference website, and I will read out your question from there. With that, I'd like to welcome Stefan to the conference. Stefan, over to you. Welcome.

Stefan Oschmann
MERCK Kommanditgesellschaft auf Aktien - Chairman of Executive Board & CEO

Thank you, Richard, and many thanks to JPMorgan for the invite. Dear ladies and gentlemen, a very warm welcome and a happy and healthy new year to all of you, both from my side as well as on behalf of my colleagues joining me for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot